LLY compared with PFE: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

PFEPfizer Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

PFEPfizer Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

LLYwithPFE

×0.26co-movement · PFE on LLY · 500d

r 0.41scale to r 0.75

Shared co-movers6with LLYwith PFE

AMGNAmgen Incr 0.41r 0.58

MRKMerck & Co., Inc.r 0.41r 0.56

BIIBBiogen Inc.r 0.40r 0.54

NVSNovartis AGr 0.39r 0.53

GSKGSK plcr 0.37r 0.53

ABBVAbbVie Inc.r 0.37r 0.49

LLY, solidPFE, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

LLYELI Lilly & Co

1,412.87▲+2.85%· post 1,417.05

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

PFEPfizer Inc

30.50▲+1.83%· post 30.46

ClosedOct 30 '26

Mkt cap$174.0BRevenue$15.0BQ2 FY26Revenue$62.6BFY25

Compare

ClosedOct 30 '26

LLYELI Lilly & Co

PFEPfizer Inc

1,412.87▲+2.85%post 1,417.05

Price

30.50▲+1.83%post 30.46

$1.3T

Mkt cap

$174.0B

Q3 FY26$24.4B

Revenue

$15.0BQ2 FY26

FY25$65.2B

Revenue

$62.6BFY25

LLY1,412.87▲+2.85%vsPFE30.50▲+1.83%ClosedOct 30 '26